The aim of our financial reporting is to create transparency by providing comprehensive information. The figures and information give an overview of the Group's economic situation. Like the annual fiscal statements, the quarterly and half-year financial statements of the Biotest Group are prepared in accordance with the standards issued by the International Accounting Standards Board (IASB), London. For more information, you may also refer to presentations.

Sustainability
Biotest is committed to its responsibility to manufacture and market vital medicines from human blood plasma with the HIGHEST SAFETY, QUALITY and EFFICIENCY in a CLIMATE-FRIENDLY WAY, while providing sustainable benefits to society, patients, employees and shareholders on our path to carbon neutrality by 2035.

Declaration of compliance with German sustainability code (DNK)
Sustainability report with non-financial declaration pursuant to section 289b, 315b HGB (German commercial code)